This study investigates pancreatic cancer. It looks at how safe and effective the FOLFIRINOX treatment is for patients who have had surgery.
The research focuses on observing patients over a long period to understand the results of using FOLFIRINOX after surgery.
- Who can participate: Adults over 19 years who have had pancreatic cancer surgery and plan to receive FOLFIRINOX can participate. Participants should have good organ function and an ECOG score of 0 or 1.
- Study details: Participants will be observed over time to see how they respond to the FOLFIRINOX treatment after surgery. The study will track their progress to understand the treatment's long-term effects.